Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 82; no. 6; pp. 1746 - 1748
Main Authors Barnes, Randall B, Ehrmann, David A
Format Journal Article
LanguageEnglish
Published Bethesda, MD Endocrine Society 01.06.1997
Subjects
Antineoplastic Agents, Hormonal - therapeutic use
Biological and medical sciences
Delayed-Action Preparations
Female
Female genital diseases
Gonadotropin-Releasing Hormone - agonists
Gynecology. Andrology. Obstetrics
Hirsutism - etiology
Humans
Leuprolide - therapeutic use
Medical sciences
Middle Aged
Non tumoral diseases
Ovarian Neoplasms - complications
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - secretion
Testosterone - antagonists & inhibitors
Testosterone - secretion
Time Factors
Endocrinopathy
Human
Hair
Skin disease
Agonist
Peptide hormone
Hirsutism
Gonadotropin RH
Long term
Female genital diseases
Hypothalamic hormone
Case study
Secretory tumor
Ovarian diseases
Ovary
Chemotherapy
Treatment
Virilism
Female
Hyperandrogenism
Tumor
Hormonal investigation
Hormone releasing factor
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0021-972X
1945-7197
DOI:10.1210/jcem.82.6.3975